Early research (Phase 1)Study completedNCT05266404
What this trial is testing
Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single Components
Who this might be right for
Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)
AstraZeneca 46